Literature DB >> 3005366

Proton secretion by the sodium/hydrogen ion antiporter in the human neutrophil.

J Wright, J H Schwartz, R Olson, J M Kosowsky, A I Tauber.   

Abstract

The reducing equivalents used by the human neutrophil respiratory burst oxidase are derived from NADPH generated by the hexose monophosphate shunt. The CO2 generated by the HMP shunt is spontaneously hydrated and the protons (H+) are secreted upon the dissociation of carbonic acid. The mechanism and significance of H+ secretion by the resting and stimulated neutrophil was investigated. A basal rate of H+ secretion by resting neutrophils observed in a choline buffer was augmented with the addition of sodium (Na+) (Km for Na+ was 3.22 +/- 0.32 mM). Amiloride, a Na+/H+ antiporter inhibitor, reduced H+ secretion in Na+-containing buffers with a Ki = 1.02 microM. This Na+/H+ exchange mechanism was also operative in cells stimulated with a variety of agonists, and an increased H+ flux, relative to resting cells, was observed at higher Na+ concentrations. Cytoplasts incorporating acridine orange were also used to assess Na+-H+ flux. Cytoplasts were used to avoid alteration of the fluorescent pH probe by HOCl formed in intact neutrophils. Alkalinization of the cytoplasm was dependent on extracellular Na+ in concentrations similar to that found to augment H+ secretion in intact cells. Also, amiloride competitively inhibited H+ secretion by the cytoplasts. Both superoxide (O2-) production and lysozyme release in cells stimulated with opsonized zymosan or concanavalin A was significantly inhibited in the absence of Na+, restored to normal with the addition of Na+ in low concentrations, and inhibited again in the presence of amiloride. A Na+/H+ antiporter similar to that found in other cell types is present in the human neutrophil and appears linked to activation of the respiratory burst and degranulation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005366      PMCID: PMC423464          DOI: 10.1172/JCI112375

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Structural and catalytic properties of the solubilized superoxide-generating activity of human polymorphonuclear leukocytes. Solubilization, stabilization in solution, and partial characterization.

Authors:  A I Tauber; E J Goetzl
Journal:  Biochemistry       Date:  1979-12-11       Impact factor: 3.162

2.  The estimation of serum lysozyme: a comparison of four assay methods.

Authors:  H J Klass; J Hopkins; G Neale; T J Peters
Journal:  Biochem Med       Date:  1977-08

3.  Chemotactic factors activate differentiable permeation pathways for sodium and calcium in rabbit neutrophils. Effect of amiloride.

Authors:  R I Sha'afi; T F Molski; P H Naccache
Journal:  Biochem Biophys Res Commun       Date:  1981-04-30       Impact factor: 3.575

4.  Characteristics of the cofactor requirements for the superoxide-generating NADPH oxidase of human polymorphonuclear leukocytes.

Authors:  D R Light; C Walsh; A M O'Callaghan; E J Goetzl; A I Tauber
Journal:  Biochemistry       Date:  1981-03-17       Impact factor: 3.162

5.  Stimulus-response coupling in the human neutrophil. Transmembrane potential and the role of extracellular Na+.

Authors:  H M Korchak; G Weissmann
Journal:  Biochim Biophys Acta       Date:  1980-09-02

Review 6.  Active oxygen species and the functions of phagocytic leukocytes.

Authors:  J A Badwey; M L Karnovsky
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

7.  On comparing regression lines with unequal slopes.

Authors:  G O Zerbe; P G Archer; N Banchero; A J Lechner
Journal:  Am J Physiol       Date:  1982-03

8.  Evidence that a Na+/Ca2+ antiport system regulates murine erythroleukemia cell differentiation.

Authors:  R L Smith; I G Macara; R Levenson; D Housman; L Cantley
Journal:  J Biol Chem       Date:  1982-01-25       Impact factor: 5.157

9.  Extracellular proton release by stimulated neutrophils.

Authors:  R van Zwieten; R Wever; M N Hamers; R S Weening; D Roos
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

10.  22Na+ fluxes in thymic lymphocytes. II. Amiloride-sensitive Na+/H+ exchange pathway; reversibility of transport and asymmetry of the modifier site.

Authors:  S Grinstein; J D Goetz; A Rothstein
Journal:  J Gen Physiol       Date:  1984-10       Impact factor: 4.086

View more
  7 in total

1.  Activation of the complement system generates antibacterial peptides.

Authors:  Emma Andersson Nordahl; Victoria Rydengård; Patrik Nyberg; D Patric Nitsche; Matthias Mörgelin; Martin Malmsten; Lars Björck; Artur Schmidtchen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-18       Impact factor: 11.205

2.  Different activation pathways involved in antibody-dependent and immune-complexes-triggered cytotoxicity mediated by neutrophils.

Authors:  J R Geffner; M Giordano; G Serebrinsky; M A Isturiz
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

3.  Antimicrobial peptides from human platelets.

Authors:  Yi-Quan Tang; Michael R Yeaman; Michael E Selsted
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

4.  Monensin disruption of neutrophil granule genesis.

Authors:  R T Parmley; J M Kinkade; D T Akin; C S Gilbert; G S Guzman
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

5.  Rapid acid extrusion response triggered by alpha(1) adrenoceptor in CHO cells.

Authors:  T Taniguchi; R Inagaki; F Suzuki; I Muramatsu
Journal:  J Physiol       Date:  2001-08-15       Impact factor: 5.182

6.  Membrane permeabilization by trypanosome lytic factor, a cytolytic human high density lipoprotein.

Authors:  John M Harrington; Sawyer Howell; Stephen L Hajduk
Journal:  J Biol Chem       Date:  2009-03-26       Impact factor: 5.157

7.  Local inflammation induces complement crosstalk which amplifies the antimicrobial response.

Authors:  Jing Zhang; Jingyun Koh; Jinhua Lu; Steffen Thiel; Benjamin S H Leong; Sunil Sethi; Cynthia Y X He; Bow Ho; Jeak L Ding
Journal:  PLoS Pathog       Date:  2009-01-30       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.